Cargando…
An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
The reversible process where a homogenous fluid de-mixes into two distinctively separate liquid phases is referred to as LLPS (Liquid-liquid phase separation). The resulting liquid is made up of one dilute phase and one condensed phase. An increasing number of studies have shown that the liquid-liqu...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685779/ http://dx.doi.org/10.1186/s43042-020-00105-0 |
_version_ | 1783613235182698496 |
---|---|
author | Durojaye, Olanrewaju Ayodeji Sedzro, Divine Mensah Mushiana, Talifhani Uzoeto, Henrietta Onyinye Cosmas, Samuel Ajima, Judith Nnedimkpa Ibiang, Glory Omini |
author_facet | Durojaye, Olanrewaju Ayodeji Sedzro, Divine Mensah Mushiana, Talifhani Uzoeto, Henrietta Onyinye Cosmas, Samuel Ajima, Judith Nnedimkpa Ibiang, Glory Omini |
author_sort | Durojaye, Olanrewaju Ayodeji |
collection | PubMed |
description | The reversible process where a homogenous fluid de-mixes into two distinctively separate liquid phases is referred to as LLPS (Liquid-liquid phase separation). The resulting liquid is made up of one dilute phase and one condensed phase. An increasing number of studies have shown that the liquid-liquid phase separation is an important principle that underlies intracellular organization in biological systems, forming liquid condensates without a membrane envelope, otherwise known as MLOs (membraneless organelles). Such organelles include the P bodies, nucleolus and stress granules. Moreover, the regulation of many other biological processes such as signal transduction, chromatin rearrangement and RNA metabolism have been linked to the liquid-liquid phase separation. |
format | Online Article Text |
id | pubmed-7685779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-76857792020-11-25 An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor Durojaye, Olanrewaju Ayodeji Sedzro, Divine Mensah Mushiana, Talifhani Uzoeto, Henrietta Onyinye Cosmas, Samuel Ajima, Judith Nnedimkpa Ibiang, Glory Omini Egypt J Med Hum Genet Correspondence The reversible process where a homogenous fluid de-mixes into two distinctively separate liquid phases is referred to as LLPS (Liquid-liquid phase separation). The resulting liquid is made up of one dilute phase and one condensed phase. An increasing number of studies have shown that the liquid-liquid phase separation is an important principle that underlies intracellular organization in biological systems, forming liquid condensates without a membrane envelope, otherwise known as MLOs (membraneless organelles). Such organelles include the P bodies, nucleolus and stress granules. Moreover, the regulation of many other biological processes such as signal transduction, chromatin rearrangement and RNA metabolism have been linked to the liquid-liquid phase separation. Springer Berlin Heidelberg 2020-11-25 2020 /pmc/articles/PMC7685779/ http://dx.doi.org/10.1186/s43042-020-00105-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Durojaye, Olanrewaju Ayodeji Sedzro, Divine Mensah Mushiana, Talifhani Uzoeto, Henrietta Onyinye Cosmas, Samuel Ajima, Judith Nnedimkpa Ibiang, Glory Omini An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor |
title | An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor |
title_full | An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor |
title_fullStr | An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor |
title_full_unstemmed | An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor |
title_short | An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor |
title_sort | in silico llps perturbation approach in the design of a novel sars-cov-2 spike receptor-binding domain inhibitor |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685779/ http://dx.doi.org/10.1186/s43042-020-00105-0 |
work_keys_str_mv | AT durojayeolanrewajuayodeji aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT sedzrodivinemensah aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT mushianatalifhani aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT uzoetohenriettaonyinye aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT cosmassamuel aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT ajimajudithnnedimkpa aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT ibianggloryomini aninsilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT durojayeolanrewajuayodeji insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT sedzrodivinemensah insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT mushianatalifhani insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT uzoetohenriettaonyinye insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT cosmassamuel insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT ajimajudithnnedimkpa insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor AT ibianggloryomini insilicollpsperturbationapproachinthedesignofanovelsarscov2spikereceptorbindingdomaininhibitor |